Abstract

The active component of acidic actinomycin congener B-1625 FA was obtained by exclusion column chromatography with Diaion HP-20 SS and aluminium oxide TLC, and was considered to be the B-1625 FA3β already reported. After repeated fractionations by aluminium oxide TLC, its FAB-MS spectrum showed the ion peak at m/z M+1 1269, C62H85O17N12 except at m/z M+1, 1343, C64H87O20N12. During the purification procedure, FA3β was found to be converted to another active product in alkaline solution. The conversion product FA-n1 obtained as a bright orange rhombic crystal was identified with actinomycin X2 (m/z M+1, 1269, C62H85O17N12). Thus FA3β was presumed to be weakly acidic by the substitution of one proton of actinomycin X2 by the group of C2H2O3.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.